X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-09-22 | ENGN | Grossman William | Interim Chief Medical Officer | P - Purchase | $1.97 | +5,102 | 5,102 | New | +$10,051 | ||||||
2024-10-30 | ENGN | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% | P - Purchase | $8.90 | +561,797 | 6,798,362 | +9% | +$4,999,993 | ||||||
| M | 2023-12-27 | ENGN | Forbion Growth Opportunities Fund I Cooperatief U.A. | 10% | P - Purchase | $6.40 | +470,633 | 6,236,565 | +8% | +$3,012,674 | |||||
2024-09-27 | ENGN | Cooper Ronald Harold Wilfred | CEO | P - Purchase | $5.70 | +10,000 | 10,000 | New | +$57,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |